Another compound derived from marijuana, cannabidinol has been used to treat epilepsy with a good deal of success. A number of drug companies are currently working to develop other compounds that can be used clinically without causing cognitive problems. One of them,Epidiolex, is currently being tested at the University of California, San Francisco, Epilepsy Center as part of an international clinical trial to evaluate its efficacy in treating epilepsy.
There are also strong suggestions that cannabinoids might be helpful in treating breast cancer, autoimmune diseases and Alzheimers disease. Ongoing research may be years away before definite conclusions can be reached, but the preliminary results are encouraging.
All of this is good news, but in the meantime remember that the federal government still lists marijuana as a Schedule 1 drug, a class with no currently accepted medical use.
No comments:
Post a Comment